Skip to main content
Premium Trial:

Request an Annual Quote

New DTC Genetics Firm Pathway Genomics Launches

NEW YORK (GenomeWeb News) – Pathway Genomics, a new direct-to-consumer genetic testing firm, launched today, offering genotyping and analysis for disease risk and heredity for under $250.

The San Diego, Calif.-based company said that its on-site lab has been certified by California regulators and has received CLIA clearance. The company said its testing enables customers to learn about disease risk, adverse drug responses, carrier status, and ancestral history.

Pathway Genomics joins a nascent field of DTC genomics providers, pioneered by 23andMe, Navigenics, and Decode Genetics among others.

The private company received its principal start-up funding from The Founders Fund, Edelson Technology Partners, and Western Technology Investment.

Pathway Genomics was founded by CEO Jim Plante, who has founded four other technology companies in the wireless, automotive, consumer products, and risk-management fields. The company's scientific team is led by CSO David Becker, who has worked in Alzheimer's research at Torrey Pines Therapeutics.

"Evaluating an individual's genetic profile is important, but it only reveals part of a person's health and wellness. The overall picture should also include information about a person's family history and lifestyle," Becker said in a statement.

Pathway Genomics is offering its testing service through its website.

The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.